H-L-MePhg-OH

H-L-MePhg-OH is an L-configured amino acid derivative in which the alpha-amino and alpha-carboxyl functionalities are presented as a free amino acid (amino acid hydrochloride salts are sometimes used for handling), while the side chain bears a methyl-substituted phenylglycine motif (MePhg). The stereogenic center at the alpha position provides defined chiral recognition for peptide coupling and stereoselective transformations, and the aromatic side chain contributes to hydrophobic and π-interaction properties relevant to peptide structure and binding studies. The carboxylic acid enables conversion to activated esters or amide-forming derivatives, while the amino group can be protected as an N-protected amino acid to control chemoselectivity during peptide assembly. As a chiral amino acid intermediate, H-L-MePhg-OH participates in protected amino acid synthesis workflows and can be carried forward into side-chain functionalization or downstream peptidomimetic scaffold construction.

1. Peptide Synthesis

H-L-MePhg-OH is applied in peptide building block preparation where the L-amino acid backbone supports standard peptide coupling chemistry after N-protection and carboxyl activation. The aromatic MePhg side chain can be retained through coupling steps to introduce hydrophobic/aromatic character into peptide sequences, and the defined alpha stereochemistry helps maintain stereochemical integrity during iterative elongation. N-protection strategies such as Boc or Fmoc-type groups can be used to suppress side reactions from the free amino functionality, enabling controlled deprotection cycles compatible with solid-phase or solution-phase synthesis. Downstream peptide analogs prepared from this amino acid can be used for structure-activity relationship studies, scaffold optimization, and mapping of aromatic side-chain contributions to binding or conformation.

2. Peptidomimetics

H-L-MePhg-OH is suitable for peptidomimetic construction in medicinal chemistry and chemical biology programs that require chiral aromatic amino acid elements. The combination of a stereodefined alpha carbon and an aromatic side chain supports incorporation into constrained analogs, where the carboxyl group can be transformed into amide, ester, or activated intermediates for further derivatization. Side-chain retention enables generation of fragments for fragment-based molecular design, while controlled N-protection and subsequent functional group interconversions can support diversification toward non-natural linkages. The resulting peptidomimetic libraries can serve as research intermediates for SAR studies and molecular recognition investigations without relying on native peptide sequences.

3. Chiral Synthesis Intermediate

H-L-MePhg-OH functions as a chiral amino acid intermediate for stereoselective synthesis routes that require an L-configured phenylglycine-like motif. The free carboxylic acid and amino functionality allow conversion into activated derivatives (for example, esterification or formation of coupling-ready species) while maintaining the stereochemical information encoded at the alpha center. Protecting-group strategies applied to the amino group enable selective functional group transformations at the carboxyl side, supporting stepwise synthesis of N-protected amino acid derivatives used in downstream manufacturing or research-scale preparations. The aromatic side chain can also guide chemoselective modifications that generate chiral intermediates for fine chemical synthesis and specialized chiral building blocks.

4. Side-Chain Functionalization

H-L-MePhg-OH is relevant to side-chain functionalization workflows where the aromatic MePhg moiety provides a handle for electrophilic substitution, cross-coupling, or oxidative derivatization strategies depending on the substitution pattern required. The amino acid framework can be protected to prevent undesired reactions during aromatic functional group installation, while the carboxyl group can be converted to an ester or activated acid form to enable orthogonal transformations. The stereogenic alpha center remains a fixed stereochemical element through protected amino acid chemistry, supporting the generation of chiral, aromatic-substituted derivatives used to tune polarity, binding interactions, or physicochemical properties. Resulting functionalized amino acid derivatives can be carried into peptide conjugates, labeling reagents, or intermediate sets for combinatorial chemistry.

5. Analytical Standards

H-L-MePhg-OH can be employed in analytical research as a reference material for amino acid profiling, method development, and chiral analysis of amino acid derivatives. The defined L-configuration and aromatic side chain provide a distinct chromatographic and spectroscopic signature that can support identification and quantification of related peptide building blocks or hydrolysis products. Conversion to N-protected or derivatized forms can improve detectability for LC-MS or GC-compatible workflows while preserving the stereochemical identity required for chiral separation studies. Analytical standards derived from this amino acid also support quality control of protected amino acid synthesis and verification of intermediate composition during peptide construction.

6. Pharmaceutical Intermediate Preparation

H-L-MePhg-OH is suitable for pharmaceutical intermediate preparation where chiral amino acid derivatives are incorporated into synthetic routes toward peptide-like small molecules and related chemical entities. The free amino acid functionality enables conversion into N-protected amino acid derivatives and activated carboxyl intermediates that participate in amide bond formation, allowing downstream assembly of complex scaffolds under controlled chemoselectivity. The aromatic side chain can be maintained as a structural element contributing to hydrophobic contacts, while protecting-group strategies support orthogonal deprotection and coupling sequences aligned with process chemistry constraints. The resulting intermediates can be used for fine chemical synthesis and specialty chemical production workflows that require reliable chiral building blocks for iterative molecular construction.

1. TMEM16F and dynamins control expansive plasma membrane reservoirs

2. Characterization of Novel P-Selectin Targeted Complement Inhibitors in Murine Models of Hindlimb Injury and Transplantation

3. Myotropic activity and immunolocalization of selected neuropeptides of the burying beetle Nicrophorus vespilloides (Coleoptera: Silphidae)

4. Relatedness of antibodies to peptides containing homocitrulline or citrulline in patients with rheumatoid arthritis

5. Oleic acid and glucose regulate glucagon-like peptide 1 receptor expression in a rat pancreatic ductal cell line